Stock Report

Alembic Pharmaceuticals Ltd passes ANVISA, Brazil GMP audit for its API-III Facility at Karakhadi



Posted On : 2023-03-24 18:21:31( TIMEZONE : IST )

Alembic Pharmaceuticals Ltd passes ANVISA, Brazil GMP audit for its API-III Facility at Karakhadi

Alembic Pharmaceuticals Limited has successfully completed the Brazilian Health Regulatory Agency (ANVISA) GMP audit at API-III Facility at Karakhadi without any observations for its 56 APIs. The inspection was conducted from 20th March, 2023 to 24th March, 2023.

Shares of Alembic Pharmaceuticals Limited was last trading in BSE at Rs. 484.45 as compared to the previous close of Rs. 488.95. The total number of shares traded during the day was 3115 in over 376 trades.

The stock hit an intraday high of Rs. 492.75 and intraday low of 483.05. The net turnover during the day was Rs. 1522687.00.

Source : Equity Bulls

Keywords

AlembicPharmaceuticals INE901L01018 ANVISA GMPAudit API3Facility Karakhadi NoObservations 56APIs